A CEO is sentenced to 51 months in prison for fraud and ordered to pay $6.1 million in restitution. Kiromic BioPharma is charged with failure to disclose material information.
Financial Crime Weekly: CEO Sentenced To 51 Months In Prison, Kiromic BioPharma Charged With Failure To Disclose Material Information
